Epic bio to present at the upcoming charles river cell and gene therapy summit

South san francisco, calif., march 13, 2024 (globe newswire) -- epic bio, a leading epigenetic editing company that plans to dose its first patients later this year, today announced that amber salzman, ph.d., chief executive officer, will present at the charles river cell & gene therapy summit at 2:00 p.m. pt, tuesday, march 19, 2024, in south san francisco, calif.
CRL Ratings Summary
CRL Quant Ranking